Delivery Order SPE2DB24D1007-SPE2DB25FCBLQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,542.37 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on August 6, 2025, with a completion date of August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded on a competitive basis and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units) with a ceiling value of $1,547.00 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within DLA's pharmaceutical procurement framework. The contract utilizes no set-aside designation, reflecting AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,094.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This non-set-aside, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen will perform this delivery order at its corporate office location in Conshohocken, Pennsylvania. The contract utilizes a firm fixed-price structure, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,128.69. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $2,665.50 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCBLQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,374.28 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price delivery order, which is not set-aside, represents a relatively small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with a completion deadline of April 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply critical medical commodities, including specialty medications, vaccines, and medical devices, to support military healthcare systems and other federal customers worldwide. AmerisourceBergen's federal contracting history demonstrates consistent competitive success across multiple therapeutic categories, positioning the company as a significant vendor within the Defense Health Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/24/25 |